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Abstract
Background: Intrauterine and postnatal overnutrition program hyperphagia, adiposity and glucose intolerance in offspring.
Single-nucleotide polymorphisms (SNPs) of the fat mass and obesity associated (FTO) gene have been linked to increased
risk of obesity. FTO is highly expressed in hypothalamic regions critical for energy balance and hyperphagic phenotypes
were linked with FTO SNPs. As nutrition during fetal development can influence the expression of genes involved in
metabolic function, we investigated the impact of maternal obesity on FTO.
Methods: Female Sprague Dawley rats were exposed to chow or high fat diet (HFD) for 5 weeks before mating, throughout
gestation and lactation. On postnatal day 1 (PND1), some litters were adjusted to 3 pups (vs. 12 control) to induce postnatal
overnutrition. At PND20, rats were weaned onto chow or HFD for 15 weeks. FTO mRNA expression in the hypothalamus and
liver, as well as hepatic markers of lipid metabolism were measured.
Results: At weaning, hypothalamic FTO mRNA expression was increased significantly in offspring of obese mothers and FTO
was correlated with both visceral and epididymal fat mass (P,0.05); body weight approached significance (P=0.07).
Hepatic FTO and Fatty Acid Synthase mRNA expression were decreased by maternal obesity. At 18 weeks, FTO mRNA
expression did not differ between groups; however body weight was significantly correlated with hypothalamic FTO.
Postnatal HFD feeding significantly reduced hepatic Carnitine Palmitoyltransferase-1a but did not affect the expression of
other hepatic markers investigated. FTO was not affected by chronic HFD feeding.
Significance: Maternal obesity significantly impacted FTO expression in both hypothalamus and liver at weaning. Early
overexpression of hypothalamic FTO correlated with increased adiposity and later food intake of siblings exposed to HFD
suggesting upregulation of FTO may contribute to subsequent hyperphagia, in line with some human data. No effect of
maternal obesity was observed on FTO in adulthood.
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Introduction
Obesity rates are rising dramatically around the globe and its
consequences represent a major public health concern [1]. Over
the last 20 years, childhood obesity rates have risen greatly, such
that they now constitute an ‘international epidemic of childhood
obesity’ [2,3,4]. Obesity results from an imbalance between energy
intake and energy expenditure, which is characterized by
increased fat stores [5]. The development of obesity is influenced
by the interaction of genetic and environmental factors [6,7].
The intrauterine environment plays a key role and suboptimal
maternal nutrition during gestation is implicated in the develop-
ment of adult metabolic diseases. It is now accepted that
nutritional changes during fetal development can predispose
individuals to obesity and metabolic disease in adult life, resetting
the expression of genes involved in energy homeostasis and
consequently altering metabolic function [8,9,10,11]. Intrauterine
over-nutrition also predisposes the fetus to obesity and metabolic
dysfunction in adulthood, and this likely contributes to the
burgeoning early onset of obesity in childhood [12,13].
Recent interest has turned to the gene-environment interactions
that underlie obesity and several genes predisposing to obesity
have been characterized [6,14]. A genome-wide search for type 2
diabetes-susceptibility genes identified a common variant in the
Fat mass and Obesity associated (FTO) gene on chromosome 16.
Adults homozygous for the risk allele were 3 kilograms heavier and
had 1.67 fold increased odds of obesity compared with those
without a risk allele; this association was observed from age 7 years
upwards predisposing individuals to diabetes through increased
BMI [15]. Substantial increases in BMI, hip circumference and
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(SNPs) in the FTO locus were associated with early-onset and
severe obesity across different ethnic cohorts [17,18,19,20,21].
The hypothalamus is the main brain region regulating food
intake, integrating peripheral signals such as leptin and insulin. In
rodents, brain FTO levels are influenced by fasting or starvation
[22,23] and a link between FTO genotype and energy intake has
been described in several human studies. The A allele was
associated with increased energy intake in children [24] and adults
[25]; AA homozygotes showed diminished satiety responsiveness
suggesting that this common risk allele may exert at least some of
its effect on appetite [26]. FTO mRNA is highly expressed in liver
and brain regions critical in the control of feeding, including the
arcuate (ARC), paraventricular (PVN), dorsomedial (DMN) and
ventromedial (VMN) nuclei [27]. Thus FTO is well placed to play
a central role in energy homeostasis and is linked to increased
adiposity and energy intake. Studies at different developmental
stages are required to fully understand the role of FTO in the
development of obesity and the regulation of energy homeostasis.
In rats, we previously showed that intrauterine and early
postnatal overnutrition altered the expression of hypothalamic
appetite stimulator neuropeptide Y (NPY) and suppressor pro-
opiomelanocortin (POMC) in offspring at weaning [28]. Maternal
obesity promoted post weaning adiposity and glucose intolerance
even when offspring consumed low-fat chow after weaning.
Moreover, a significant additive impact with post weaning high
fat diet (HFD) consumption was observed, markedly exaggerating
metabolic disorders in offspring of obese mothers [29].
It is not known whether FTO is regulated by different levels of
maternal nutrition, nor whether food intake is influenced by
expression levels of FTO from an early age. To this end we
examined the impact of maternal obesity and early life
overnutrition induced by litter size reduction on FTO expression
in the hypothalamus. As FTO has been linked to energy intake, we
examined the association between hypothalamic FTO mRNA
expression at weaning, and subsequent energy intake in groups of
siblings weaned onto either low fat chow or HFD. As FTO
expression in the liver has been linked to blood glucose levels [30],
we also examined liver FTO mRNA expression in offspring from
obese mothers at different pos tnatal ages along with other markers
involved in lipid metabolism. Our results indicate an early impact
of maternal obesity to up-regulate hypothalamic FTO, which
correlated with increased subsequent intake of palatable HFD. At
weaning, hepatic FTO expression was decreased by maternal
obesity. No effect of maternal obesity on liver or hypothalamic
FTO was observed in adult rats. Further, no effect of chronic
palatable diet consumption on FTO was observed in either
hypothalamus or liver.
Materials and Methods
All animal work was approved by the Animal Care and Ethics
Committee of the University of New South Wales, #06/60B.
Maternal Obesity
Virgin female Sprague Dawley rats aged 9 weeks (Animal
Resource Centre, WA, Australia) were housed at 2062uC and
maintained on a 12:12 h light/dark cycle. Rats were assigned to
two groups of equal average starting body weight and were fed
either a control or a high fat diet (HFD) during gestation and
lactation. Mothers in the control (n=11) group were fed standard
laboratory chow (11 kJ/g, energy 14% fat, 21% protein, 65%
carbohydrate, Gordon’s Specialty Stockfeeds, NSW, Australia),
whereas those in the HFD (n=9) group were fed a cafeteria diet
consisting of a range of western foods (pies, cake, dim sim)
supplemented with chow with added condensed milk and
saturated animal fat (15.3 kJ/g, energy 34% fat, 18% protein,
and 50% carbohydrate) as described previously [28,29]. The
animals used in this study were the same as those used in previous
published studies [28,29]. After 5 weeks females were mated and
consumed the same diet during gestation and lactation until pups
were weaned at 20 days (Fig. 1).
Postnatal Litter size adjustment and post weaning HFD
feeding
On day 1 after birth, some litters were adjusted to 3 pups (small
litter), versus normal litters maintained at 12 pups, yielding 4
groups where first letter corresponds to the diet during gestation
and the second letter to the litter size adjustment; (CN) chow-fed
dam with normal-size litter; (CS) chow-fed dam with small-size
litter; (HN) HFD-fed dam with normal-size litter; (HS) HFD-fed
mum with small-size litter. At 20 days, half the male pups from
each litter were weaned onto chow, while the other half were given
HFD (Fig. 1).
Sample Collection
Two time points were examined. At 20 days pups were deeply
anesthetized (ketamine/xylazine 180/32 mg/kg, i.p.) prior to
decapitation. At this age 12, 13, 12 and 12 pups were sampled
from CN, CS, HN and HS groups respectively. At 18 weeks group
sizes ranged from 10 to 12 rats. Animals were fasted overnight
(14 h), then anesthetized (ketamine/xylazine 180/32 mg/kg, i.p.),
naso-anal (N-A) length measured, blood was collected by cardiac
puncture and rats were decapitated. Brains were rapidly removed
and whole hypothalamus was dissected at 20 days while at 18
weeks the ventral hypothalamus containing ARC was dissected
[29]. Livers were dissected, weighed, frozen in liquid nitrogen and
stored at 280 C for subsequent RNA extraction.
Haematoxylin and eosin staining
At 18 weeks a section of liver from each rat (n=10–12 per
group) was placed in 4% formaldehyde overnight, transferred to
70% ethanol, embedded in paraffin wax and stained for
Hematoxylin and eosin. Fatty change in the liver was graded by
an observer blinded to the treatment. The amount and size of lipid
filled vacuoles present was graded with 0 if no evidence of lipid
vacuoles; 1 few small lipid vacuoles present within hepatocytes; 2
increased number and larger lipid vacuoles within hepatocytes.
Figure 1. Experimental groups. Sprague Dawley dams were fed
chow or HFD prior to mating and during gestation and lactation. The
offspring were raised in either normal (12) or small (3) size litters. The
first letter represents maternal diet and the second letter litter size. At
weaning, n=12–13 rats were sampled from CN, CS, HN and HS groups.
After weaning half the remaining rats from each of these groups were
fed either chow or HFD, yielding 8 groups, each comprising 10–12 rats .
doi:10.1371/journal.pone.0025261.g001
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Quantitative Real Time PCR
RNA was extracted using Tri-reagent (Sigma, St. Louis, MO,
USA) and stored at 280C (n=6–8 per group). Spectrophotometric
quantification using Biospec-nano spectrophotometer (Shimadzu
Biotech, Nakagyo-ku, Kyoto, Japan) determined RNA concentra-
tion and purity. One mg of RNA was reverse transcribed
simultaneously to cDNA using the Omniscript Reverse Transcrip-
tion kit (Qiagen, Valencia, CA, USA) following manufacturer’s
instructions, and stored at 220uC. Preoptimized TaqMan probe/
primers labeled with FAM (Applied Biosystems, Foster City, USA)
were used for quantitative real-time PCR (Realplex 2; Eppendorf,
Hamburg, Germany) on the following target genes: Fat mass and
obesity associated (FTO), Rn01538187_m1; Sterol regulatory
element binding protein 1c (SREBP-1C), Rn01446563_m1; Fatty
acid synthase (FAS), Rn00569117_m1; Carnitine palmitoyltransfer-
ase 1a (CPT1a) Rn00580702_m1. Probes for the gene of reference
(Beta Actin) were labeled with VIC. Target gene expression was
quantified by single-plexing reaction and normalized by the gene of
reference (beta actin). A sample from the control group was used as
a calibrator. Analysis was performed using the
DDCT method [31].
Statistical analysis
Statistical analysis were performed using the SPSS 17.0
Windows software (SPSS Inc., Chicago, Il) and results were
expressed as mean 6 SEM. Anthropomorphic, hormone and gene
expression data were analyzed by one or two-way ANOVA
depending on number of treatment groups, followed by a post hoc
analysis using the least significant difference test (LSD) as
appropriate. Liver score was analyzed by Wilcoxon matched-pairs
signed rank test. Correlations between parameters measured were
assessed by Pearson tests. Results were considered statistically
significant when P,0.05.
Results
Effect of maternal and postnatal overnutrition on pups at
weaning
As previously reported HFD mothers weighed 23% more than
control at the time of mating and their offspring were heavier by
seven days of age [28]. Pups raised in small litters had greater
weight gain than those from normal size litters independent of
maternal diet [28,29]. Fat mass was increased significantly by both
pre and postnatal overnutrition and leptin was higher in pups from
obese mothers (HN and HS) [29].
Liver histology
At 18 weeks, scoring of liver sections revealed that post-weaning
HFD increased lipid accumulation within hepatocytes in all groups
independently of maternal diet and litter size adjustment (P,0.05,
Fig. 2).
Central appetite regulators at weaning and food intake
of siblings
Hypothalamic FTO mRNA expression was increased in
offspring of obese mothers (P=0.024; n=30; Fig. 3). FTO
mRNA at weaning was significantly correlated with both visceral
(P=0.005; n=30; r=0.459) and epididymal (P=0.005; n=30;
r=0.476; Fig. 4 A and B) fat mass; the relationship with body
weight approached significance (P=0.07; n=30; r=0.333).
We next examined the relationship between FTO mRNA
expression of rats killed at weaning and food intake of their siblings
over time across each treatment group. When group means were
examined, FTO mRNA expression was positively correlated with
total energy intake in the four groups of adult rats fed HFD
(r=0.963; P=0.037), but not in those fed chow. We also observed
a significant correlation between FTO mRNA expression at
weaning and adiposity in HFD fed siblings at 18 weeks (r=0.96;
P=0.04). In adult rats fed HFD, Area Under the Curve (AUC) of
glucose during the Glucose Tolerance Test [29] was correlated
with weaning hypothalamic FTO mRNA expression of siblings
from the same treatment group (r=0.96; P=0.04); no association
was observed in those fed chow.
Figure 2. Average of liver score at 18 weeks. Liver score was
analyzed by Wilcoxon matched-pairs signed rank test and results
expressed as the mean 6 SEM (n=10–12 per group). CN: chow-fed
mother with normal size litter. CS: chow-fed mother with small size
litter. HN: HFD-fed mother with normal size litter. HS: HFD-fed mother
with small size litter. Post weaning chow diet: open bars; post weaning
HFD: closed bars. #, Significant post weaning diet effect: P,0.05.
doi:10.1371/journal.pone.0025261.g002
Figure 3. Hypothalamic FTO mRNA expression at weaning.
Results are expressed as mean 6 SEM (n=6–8 per group); CN: chow-fed
mother with normal size litter. CS: chow-fed mother with small size
litter. HN: HFD-fed mother with normal size litter. HS: HFD-fed mother
with small size litter. Data were analyzed by two-way ANOVA. *,
Significant overall maternal diet effect P,0.05.
doi:10.1371/journal.pone.0025261.g003
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At 18 weeks, no effect of maternal diet, litter size adjustment as
well as postweaning diet on FTO mRNA expression was observed
(Fig. 5). However, adult body weight was correlated with
hypothalamic FTO mRNA expression (r=0.24; P=0.05; n=48)
as well as brown adipose tissue mass (r=0.24; P=0.04; n=48)
and plasma insulin (r=0.21; P=0.01; n=48). We also observed a
correlation with hypothalamic FTO and circulating triglyceride
levels (r=0.24; P=0.04; n=46), but not with total fat mass
(r=0.22; P=0.06; n=48).
Hepatic FTO and lipid regulators at weaning
We measured key hepatic genes involved in lipid metabolism:
SREBP-1c, FAS and CPT-1a (Fig. 6). Liver FTO (P=0.049) and
FAS (P=0.037) mRNA expression was decreased by maternal
overnutrition in both HN and HS groups. CPT-1a and SREBP-1c
mRNA expression remained unchanged. There was no litter size
effect on the expression of hepatic markers investigated. Hepatic
mRNA FTO expression was strongly correlated with the fatty acid
oxidative gene CPT-1a (r=0.62; P=0.001; n=33) and with the
lipogenic SREBP-1c and FAS (r=0.906; P=0.001; n=33).
Furthermore, all hepatic markers investigated involved in lipid
metabolism were significantly correlated (P,0.05).
Hepatic FTO and lipid regulators in adult
At 18 weeks, maternal diet and litter size adjustment as well as
postnatal overnutrition did not significantly affect hepatic FTO
mRNA expression (Fig. 7). FTO mRNA expression was correlated
with hepatic FAS (r=0.32; P=0.01; n=54) and CPT-1a (r=0.45;
P=0.01; n=53). Postnatal HFD reduced the expression of hepatic
CPT-1a (P=0.014; n=54) which was negatively correlated with
blood glucose (r=20.41; P=0.02; n=54), fasting insulin
(r=20.32; P=0.02; n=52) and HOMA levels (r=20.35;
P=0.01; n=52). Maternal diet, litter size adjustment and
postnatal overnutrition did not change the expression of the other
hepatic markers involved in lipid metabolism.
Discussion
In this study we examined the impact of maternal obesity and
early life overnutrition on FTO expression in the hypothalamus
and liver_ENREF_18. The novel finding of this study is that
maternal obesity impacts FTO expression in young animals, with
reduced impact in adulthood. Moreover, the cohort who had
increased hypothalamic FTO expression at weaning consumed
more energy in adulthood, but notably, this occurred only in
offspring consuming palatable HFD. Modest postweaning over-
feeding induced by litter size reduction had no impact on FTO,
and there was no effect of HFD consumption on FTO expression.
In animals, FTO is expressed in feeding related areas and
overexpression leads to increased food intake [22,32]. We
previously demonstrated that intrauterine and early postnatal
overnutrition due to litter size reduction altered the expression of
NPY and POMC in offspring at weaning [28], as well as their
response to fasting. Our data suggest that environmental-dietary
factors can also impact hypothalamic FTO expression. At
weaning, hypothalamic FTO was significantly upregulated in rats
from HFD mothers confirming the crucial impact of maternal diet
on the programming of hypothalamic neuroendocrine circuitry.
Our results suggest that overexpression of hypothalamic FTO at
weaning may lead to a hyperphagic phenotype in adulthood due
to differences in food intake or dietary preference, in line with
other studies on human [15,19,24] demonstrating an association
with FTO SNPs and increased intake. Increased energy intake in
adulthood was seen in offspring of obese mothers, but only when
rats were fed HFD [29]. This suggests that FTO may be involved
Figure 4. Correlation between hypothalamic FTO mRNA expression and fat mass at weaning. A) Visceral fat mass (n=30; r=0.459;
P,0.005); B) Epididymal fat mass (n=30; r=0.476; P,0.005).
doi:10.1371/journal.pone.0025261.g004
Figure 5. FTO mRNA expression in the ARC at 18 weeks. Results
are expressed as mean 6 SEM (n=6–7) of animals consuming post
weaning chow diet (open bars) and HFD (closed bars). CN: chow-fed
mother with normal size litter. CS: chow-fed mother with small size
litter. HN: HFD mother with normal size litter. HS: HFD mother with
small size litter.
doi:10.1371/journal.pone.0025261.g005
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PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e25261Figure 6. mRNA expression of hepatic markers at weaning. Results are expressed as mean 6 SEM (n=6–8). (A) FTO mRNA expression, (B) FAS,
(C) CPT-1c, (D) SREBP-1c; CN: chow-fed mother with normal size litter. CS: chow-fed mother with small size litter. HN: HFD mother with normal size
litter. HS: HFD mother with small size litter. Data were analyzed by two-way ANOVA.*, Significant overall maternal diet effect P,0.05.
doi:10.1371/journal.pone.0025261.g006
Figure 7. mRNA expression of hepatic markers at 18 weeks. Results are expressed as mean 6 SEM (n=6–8) of animals consuming post
weaning chow diet (open bars) and HFD (closed bars). (A) FTO mRNA expression, (B) FAS, (C) CPT-1c, (D) SREBP-1c; CN: chow-fed mother with normal
size litter. CS: chow-fed mother with small size litter. HN: high fat diet-fed mother with normal size litter. HS: high-fat diet-fed mother with small size
litter. Bar indicates significant overall effect of postweaning diet (P=0.014).
doi:10.1371/journal.pone.0025261.g007
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required to test this. Nonetheless an early increase in hypothalamic
FTO mRNA expression due to maternal obesity may affect
offspring energy homeostasis and their metabolism in adulthood.
Early in life hypothalamic FTO expression was correlated with
fat mass, but in adulthood, the relationship between FTO and
adiposity appeared to be less distinct. At 18 weeks our data did not
show a significant correlation of FTO with total fat mass, in line
with some human studies where the effects of FTO on body
composition weakened with age [33,34]. At this time point,
maternal diet, litter size adjustment or postweaning diet did not
affect the expression of FTO in the hypothalamus although it was
significantly correlated with body weight, plasma insulin and
triglyceride levels.
Hypothalamic FTO mRNA expression at weaning was
significantly correlated with AUC of glucose of their adult siblings
consuming HFD, but it is difficult to draw conclusions regarding
causality. Indeed increased body weight in siblings of rats from
obese mothers fed HFD may explain the reduction in glucose
tolerance compared to those eating standard chow [29] as in
humans the link between FTO SNPs and diabetes was abolished
by BMI adjustment [15]. However, a plausible early role of FTO
in the glucose metabolic pathway cannot be excluded. In humans,
Hertel et al. have recently shown variants of FTO are associated
with type 2 diabetes even after correction for BMI [35], although
in some other studies the association is explained by the increased
adiposity [36,37]. To date, the mechanisms behind this relation-
ship remain elusive. FTO was widely expressed in fetal brain [15]
and it would also be of interest to determine whether changes in
FTO expression may be present earlier in life in offspring
following maternal obesity, as we have shown changes in
hypothalamic appetite regulators are present by birth [38].
FTO is also expressed in metabolic tissues [30,39,40], however
little is known concerning the role of maternal obesity and the
expression of hepatic FTO. Increased metabolic disorders in
childhood have been linked to maternal obesity [41] and several
studies in animal models revealed that altered nutritional status
during gestation and early postnatal period predisposed offspring
to the development of severe hepatic steatosis [42,43,44,45]. The
physiological function of FTO in the liver is still unclear. Here,
hepatic FTO expression was significantly reduced in offspring of
obese mothers at weaning. We also investigated hepatic markers
involved in lipid metabolism such as CPT-1a, SREBP-1c and FAS
at two time points. The lipogenic gene SREPB-1c is normally
expressed in adipocytes and involved in their differentiation
[46,47]. In mammals, SREPB-1c plays a critical role for FAS
induction of lipogenesis [48,49]. At weaning, maternal obesity was
associated with downregulated hepatic FAS expression, with no
change in the other hepatic markers investigated, although they
were significantly correlated with FTO. Overnutrition due to litter
size adjustment had no effect on hepatic FTO expression as well as
that of other markers investigated. Hepatic FTO expression at
weaning in rats from HFD fed mothers was significantly correlated
with the fatty acid oxidative CPT-1a, SREPB-1c and FAS
supporting an involvement of FTO in the regulation of hepatic
lipid metabolism.
At 18 weeks, no marked changes in hepatic FTO were observed
in response to any of the interventions. Few reports of
physiological alterations in hepatic FTO mRNA expression exist,
with one study showing fasting increased the expression of hepatic
FTO in mice [30]. The precise function of FTO in the liver is not
clear, and investigation of liver-specific over- and under-expression
of FTO would be informative in this regard. Post-weaning HFD
significantly decreased the expression of the hepatic oxidative gene
CPT-1a. Decreased hepatic CPT-1a expression has been associ-
ated with reduced ability to oxidize long chain fatty acids [50,51]
although discrepancies regarding the expression of the gene
CPT1-a due to nutritional state and micronutrient component of
the diet have been reported [52,53]. As we expected, histological
scoring of the liver sections revealed postweaning HFD signifi-
cantly exacerbated accumulation of lipid vacuoles within hepato-
cytes inducing steatosis.
In summary, our data suggest that maternal obesity may have an
impact in programming the metabolic state of subsequent
generations through modulation of liver and hypothalamic FTO
early in life. Our findings link the deleterious impact of a
suboptimal intrauterine environment induced by pre-existing
maternal obesity with early increased hypothalamic FTO and
subsequent development of a hyperphagic phenotype when
challenged with a palatable HFD. Thus, FTO may contribute to
the programming of obesity through both central and peripheral
mechanisms. Additional studies are required to fully elucidate the
role of FTO in liver.
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